ArticleCommunications biology2026
Porcine epidemic diarrhea virus suppresses DHX9-mediated antiviral transcription through its nucleocapsid protein.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine epidemic diarrhea virus (PEDV) causes an enteric disease in piglets and leads to economic losses in the swine industry. Antiviral defense depends on interferon responses, yet how PEDV suppresses antiviral transcription remains incompletely understood. We show that DExH-box helicase 9 (DHX9) functions as a host restriction factor that is antagonized by the PEDV nucleocapsid (N) protein. PEDV infection decreases DHX9 protein abundance without affecting DHX9 transcript levels. DHX9 overexpression restricts PEDV replication, whereas DHX9 depletion enhances viral replication. Mechanistically, DHX9 forms a transcriptional complex with signal transducer and activator of transcription 1 (STAT1) and RNA polymerase II to promote interferon-stimulated gene (ISG) expression. The PEDV N protein binds the STAT1-interacting region of DHX9 and disrupts assembly of the DHX9-STAT1-RNA polymerase II complex, suppressing antiviral transcription. In parallel, the N protein promotes ubiquitination and proteasome-dependent degradation of DHX9 by enhancing its interaction with the E3 ubiquitin ligase MDM2, attenuating STAT1-associated antiviral signaling. Together, these findings identify DHX9 as a regulator of antiviral transcription during PEDV infection and reveal how PEDV suppresses antiviral responses through disruption and degradation of DHX9. This work provides insights into coronavirus immune evasion and suggests that the PEDV N-DHX9 axis may represent a target for antiviral strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.